We are live on
!
Find out more
GC
Grimes & Company Portfolio holdings
AUM
$3.61B
1-Year Est. Return
18.46%
This Fund
S&P 500
This Quarter
Est. Return
+6.55%
1 Year Est. Return
+18.46%
3 Year Est. Return
+45.37%
5 Year Est. Return
+55.88%
10 Year Est. Return
+230.11%
AUM
$4.05B
AUM Growth
+$375M
(+10%)
Cap. Flow
+$164M
Cap. Flow
% of AUM
4.05%
Top 10 Holdings %
Top 10 Hldgs %
45.11%
Holding
463
New
50
Increased
205
Reduced
169
Closed
13
Top Buys
| 1 |
Vanguard Small-Cap ETF
VB
|
+$123M |
| 2 |
Invesco S&P 500 Equal Weight ETF
RSP
|
+$25.6M |
| 3 |
State Street Materials Select Sector SPDR ETF
XLB
|
+$20.7M |
| 4 |
State Street Energy Select Sector SPDR ETF
XLE
|
+$15.8M |
| 5 |
Avantis US Large Cap Equity ETF
AVLC
|
+$7.25M |
Top Sells
| 1 |
iShares Short-Term National Muni Bond ETF
SUB
|
+$57.9M |
| 2 |
State Street Communication Services Select Sector SPDR ETF
XLC
|
+$31.3M |
| 3 |
State Street Industrial Select Sector SPDR ETF
XLI
|
+$19.2M |
| 4 |
lululemon athletica
LULU
|
+$6.88M |
| 5 |
Apple
AAPL
|
+$4.87M |
Sector Composition
| 1 | Technology | 14.03% |
| 2 | Healthcare | 5.35% |
| 3 | Financials | 4.48% |
| 4 | Communication Services | 3.26% |
| 5 | Industrials | 2.97% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
426
Agilent Technologies
A
$37.9B
| $222K | 0.01% |
1,729
-28
| -2% | -$3.38K |
|
427
TG Therapeutics
TGTX
$8.42B
| $220K | 0.01% |
6,100
| – | – |
|
428
Energy Transfer Partners
ET
$69.4B
| $220K | 0.01% |
12,831
+317
| +3% | +$5.56K |
|
429
Solventum
SOLV
$13.4B
| $220K | 0.01% |
3,009
| – | – |
|
430
Electronic Arts
EA
$51.7B
| $219K | 0.01% |
+1,085
| New | +$180K |
|
431
American International
AIG
$42.4B
| $215K | 0.01% |
2,741
+27
| +1% | +$2.16K |
|
|
HOLX
432
DELISTED
Hologic
HOLX
| $214K | 0.01% |
3,176
-5
| -0.2% | -$332 |
|
433
Old Dominion Freight Line
ODFL
$48.4B
| $209K | 0.01% |
1,482
+31
| +2% | +$4.75K |
|
434
State Street SPDR S&P Bank ETF
KBE
$1.53B
| $207K | 0.01% |
+3,484
| New | +$205K |
|
435
HCA Healthcare
HCA
$86.7B
| $207K | 0.01% |
+485
| New | +$188K |
|
436
Innoviva
INVA
$1.64B
| $207K | 0.01% |
11,324
| – | – |
|
437
Mondelez International
MDLZ
$76.8B
| $203K | 0.01% |
3,253
-72
| -2% | -$4.64K |
|
438
Autodesk
ADSK
$44.8B
| $203K | 0.01% |
638
-177
| -22% | -$53.9K |
|
439
Zoetis
ZTS
$31.6B
| $202K | 0.01% |
1,379
-30
| -2% | -$4.54K |
|
440
ADMA Biologics
ADMA
$2.08B
| $200K | ﹤0.01% |
13,674
| – | – |
|
|
FOLD
441
DELISTED
Amicus Therapeutics
FOLD
| $192K | ﹤0.01% |
24,383
+456
| +2% | +$3.25K |
|
442
Ford
F
$55.2B
| $154K | ﹤0.01% |
12,866
+20
| +0.2% | +$230 |
|
443
ImmunityBio
IBRX
$8.16B
| $144K | ﹤0.01% |
58,436
| – | – |
|
444
Digimarc Corp
DMRC
$154M
| $130K | ﹤0.01% |
13,271
| – | – |
|
|
UROY
445
Uranium Royalty Corp
UROY
$388M
| $129K | ﹤0.01% |
30,000
| – | – |
|
446
Iovance Biotherapeutics
IOVA
$1.8B
| $94.1K | ﹤0.01% |
43,345
+5,506
| +15% | +$13K |
|
|
BCG
447
Binah Capital Group
BCG
$24.9M
| $57.6K | ﹤0.01% |
+33,482
| New | +$65.5K |
|
448
Ironwood Pharmaceuticals
IRWD
$693M
| $53.7K | ﹤0.01% |
40,994
| – | – |
|
449
Rocket Pharmaceuticals
RCKT
$406M
| $50.2K | ﹤0.01% |
+15,411
| New | +$48.5K |
|
450
Ribbon Communications
RBBN
$402M
| $38.1K | ﹤0.01% |
10,030
| – | – |
|
Similar funds
WB
OCM
AF
CMC
SL
U
MMA
FMII